Elevation Oncology Inc (NASDAQ:ELEV)’s 12-Month Price Target Currently Stands At 10
In recent trading session, Elevation Oncology Inc (NASDAQ:ELEV) saw 0.45 million shares changing hands at last check today with its beta currently measuring 1.21. Company’s